Skip to main content

Table 1 Characteristics of the patients

From: Association between fasting blood glucose levels at admission and overall survival of patients with pancreatic cancer

  All (n = 253) Normal blood glucose (n = 94) Hyperglycemia (n = 159) P
Age, years, median (range) 60 (37,83) 60 (37,80) 61 (38,83) 0.516
BMI, median (range) 23.3 (12.4,32.1) 22.3 (15.5,29) 23.5 (12.4,32.1) 0.039
Sex, n (%)     0.002
 Female 106 (41.7%) 27 (28.7%) 79 (49.4%)  
 Male 148 (58.5%) 67 (71.3%) 81 (50.9%)  
Smoking history, n (%) 93 (36.8%) 46 (48.9%) 47 (29.6%) 0.002
Drinking history, n (%) 49 (19.4%) 21 (22.3%) 28 (17.7%) 0.370
Diabetes history, n (%) 65 (25.7%) 7 (7.4%) 58 (36.5%) < 0.001
Hypertension history, n (%) 70 (27.7%) 19 (20.2%) 51 (32.1%) 0.042
Allergic history, n (%) 33 (13%) 7 (7.4%) 26 (16.4%) 0.042
Abdominal pain, n (%) 174 (69.9%) 69 (74.2%) 105 (67.3%) 0.252
Back pain, n (%) 38 (15.3%) 17 (18.3%) 21 (13.5%) 0.306
Anorexia, n (%) 10 (4%) 2 (2.2%) 8 (5.1%) 0.329
Loss of appetite, n (%) 106 (42.6%) 37 (39.8%) 69 (44.2%) 0.493
Loss of weight, n (%) 154 (61.8%) 50 (53.8%) 104 (66.7%) 0.043
CA199, n (%)     0.383
 Normal 51 (21.9%) 22 (24.7%) 29 (20.1%)  
 37–1000 147 (63.1%) 57 (64%) 90 (62.5%)  
  > 1000 35 (15%) 10 (11.2%) 25 (17.4%)  
Surgical procedure, n (%)     0.932
 Whipple 192 (75.9%) 73 (77.7%) 119 (74.8%)  
 Distal 52 (20.6%) 18 (19.1%) 34 (21.4%)  
 Other 9 (3.6%) 3 (3.2%) 6 (3.8%)  
Site of onset, n (%)     0.790
 Head of pancreas 201 (79.8%) 75 (80.6%) 126 (79.2%)  
 Tail of pancreas 51 (20.2%) 18 (19.4%) 33 (20.8%)  
Differentiation, n (%)     0.613
 Poor 61 (24.1%) 21 (22.3%) 40 (25.2%)  
 Moderate-high 192 (75.9%) 73 (77.7%) 119 (74.8%)  
AJCC8 staging     0.677
 Stage I 121 (47.8%) 48 (51.1%) 73 (45.9%)  
 Stage II 86 (34%) 31 (33%) 55 (34.6%)  
 Stage III-IV 46 (18.2%) 15 (16%) 31 (19.5%)  
Obstructive jaundice 129 (51%) 44 (46.8%) 85 (53.5%) 0.307
Follow-up time, months, median (range) 16.5 (0.1,95) 20.9 (0.5,95) 14.2 (0.1,93.3) 0.327
  1. BMI body mass index, CA cancer antigen, AJCC American Joint Committee on Cancer